Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Overnight Switch From Rasagiline To Safinamide In Fluctuating Patients With Parkinson's Disease: A Tolerability And Safety Study

NCT03843944 is registered in ClinicalTrials.gov with IRCCS San Raffaele Roma as lead sponsor.

NCT NCT03843944
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03843944 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Overnight Switch From Rasagiline To Safinamide In Fluctuating Patients With Parkinson's Disease: A Tolerability And Safety Study
Lead sponsor
IRCCS San Raffaele Roma
Phase
Phase 4
Overall status
Completed
Start date
May 1, 2018
Completion date
May 31, 2019
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease